7 results
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Superficial - Active Bleeding ... LowerExtremity #Veins ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
UpperExtremity #Veins ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Anatomy #Anticoagulation ... #Algorithm
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
points: Active bleeding ... Management #VTE #DVT ... #Algorithm #Venous ... Thromboembolism #Treatment #Hematology ... #Anticoagulation
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Consensus 2019: Duration ... of Therapy for Venous ... • Superficial Venous ... Bloodman #VTE #anticoagulation ... #DVT #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... mass index; VTE = venous ... #Anticoagulation ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Isolated distal DVT ... Unprovoked proximal DVT ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... ET-associated mutation ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... (if history of venous